This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2006 Sep 9;368(9539):893-4.

doi: 10.1016/S0140-6736(06)69293-3.

Does the metabolic syndrome help to select patients requiring high statin dose?

A J Scheen¹

Affiliations

PMID: 16962860
DOI: 10.1016/S0140-6736(06)69293-3

Free article

Comment

Does the metabolic syndrome help to select patients requiring high statin dose?

A J Scheen. Lancet. 2006.

Free article

. 2006 Sep 9;368(9539):893-4.

doi: 10.1016/S0140-6736(06)69293-3.

Author

A J Scheen¹

Affiliation

¹ Department of Medicine, CHU Sart Tilman (B35), B-4000 Liège, Belgium. andre.scheen@chu.ulg.ac.be

PMID: 16962860
DOI: 10.1016/S0140-6736(06)69293-3

No abstract available

PubMed Disclaimer

Comment on

Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study.
Deedwania P, Barter P, Carmena R, Fruchart JC, Grundy SM, Haffner S, Kastelein JJ, LaRosa JC, Schachner H, Shepherd J, Waters DD; Treating to New Targets Investigators. Deedwania P, et al. Lancet. 2006 Sep 9;368(9539):919-28. doi: 10.1016/S0140-6736(06)69292-1. Lancet. 2006. PMID: 16962881 Clinical Trial.

Similar articles

Aggressive low-density lipoprotein cholesterol lowering in secondary prevention of coronary heart disease.
Clearfield M. Clearfield M. Curr Atheroscler Rep. 2006 Jan;8(1):7-8. Curr Atheroscler Rep. 2006. PMID: 16455005 No abstract available.
Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study.
Deedwania P, Barter P, Carmena R, Fruchart JC, Grundy SM, Haffner S, Kastelein JJ, LaRosa JC, Schachner H, Shepherd J, Waters DD; Treating to New Targets Investigators. Deedwania P, et al. Lancet. 2006 Sep 9;368(9539):919-28. doi: 10.1016/S0140-6736(06)69292-1. Lancet. 2006. PMID: 16962881 Clinical Trial.
Cholesterol lowering in patients with CHD and metabolic syndrome.
Caputo F, Bernardi M. Caputo F, et al. Lancet. 2007 Jan 6;369(9555):26; author reply 26-7. doi: 10.1016/S0140-6736(07)60023-3. Lancet. 2007. PMID: 17208635 No abstract available.
Atorvastatin.
Hyatt PJ. Hyatt PJ. Br J Hosp Med. 1997 Oct 1-14;58(7):333-6. Br J Hosp Med. 1997. PMID: 9509055 Review. No abstract available.
[Statins: for the time being, do not as a rule prescribe the maximum dose].
Smulders YM. Smulders YM. Ned Tijdschr Geneeskd. 2005 Aug 20;149(34):1876-8. Ned Tijdschr Geneeskd. 2005. PMID: 16136739 Review. Dutch.

See all similar articles

Cited by

Cannabinoid type 1 receptor mediates depot-specific effects on differentiation, inflammation and oxidative metabolism in inguinal and epididymal white adipocytes.
Wagner IV, Perwitz N, Drenckhan M, Lehnert H, Klein J. Wagner IV, et al. Nutr Diabetes. 2011 Sep 5;1(9):e16. doi: 10.1038/nutd.2011.12. Nutr Diabetes. 2011. PMID: 23455155 Free PMC article.
Efficacy and Safety of PCSK9 Inhibition With Evolocumab in Reducing Cardiovascular Events in Patients With Metabolic Syndrome Receiving Statin Therapy: Secondary Analysis From the FOURIER Randomized Clinical Trial.
Deedwania P, Murphy SA, Scheen A, Badariene J, Pineda AL, Honarpour N, Keech AC, Sever PS, Pedersen TR, Sabatine MS, Giugliano RP. Deedwania P, et al. JAMA Cardiol. 2021 Feb 1;6(2):139-147. doi: 10.1001/jamacardio.2020.3151. JAMA Cardiol. 2021. PMID: 32785614 Free PMC article. Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- ORBi (University of Liege)
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information